BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12612865)

  • 1. Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.
    Risch N; Tang H; Katzenstein H; Ekstein J
    Am J Hum Genet; 2003 Apr; 72(4):812-22. PubMed ID: 12612865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possibility of a selection process in the Ashkenazi Jewish population.
    Zlotogora J; Bach G
    Am J Hum Genet; 2003 Aug; 73(2):438-40; author reply 440-1. PubMed ID: 12868052
    [No Abstract]   [Full Text] [Related]  

  • 3. Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis.
    Frisch A; Colombo R; Michaelovsky E; Karpati M; Goldman B; Peleg L
    Hum Genet; 2004 Mar; 114(4):366-76. PubMed ID: 14727180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: evidence of genetic drift within the Ashkenazim.
    Niell BL; Long JC; Rennert G; Gruber SB
    Am J Hum Genet; 2003 Dec; 73(6):1250-60. PubMed ID: 14624392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations.
    Behar DM; Garrigan D; Kaplan ME; Mobasher Z; Rosengarten D; Karafet TM; Quintana-Murci L; Ostrer H; Skorecki K; Hammer MF
    Hum Genet; 2004 Mar; 114(4):354-65. PubMed ID: 14740294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel.
    Kerem E; Kalman YM; Yahav Y; Shoshani T; Abeliovich D; Szeinberg A; Rivlin J; Blau H; Tal A; Ben-Tur L
    Hum Genet; 1995 Aug; 96(2):193-7. PubMed ID: 7635469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease-causing variants.
    Shi L; Webb BD; Birch AH; Elkhoury L; McCarthy J; Cai X; Oishi K; Mehta L; Diaz GA; Edelmann L; Kornreich R
    Clin Genet; 2017 Apr; 91(4):599-604. PubMed ID: 27415407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population.
    Behar DM; Hammer MF; Garrigan D; Villems R; Bonne-Tamir B; Richards M; Gurwitz D; Rosengarten D; Kaplan M; Della Pergola S; Quintana-Murci L; Skorecki K
    Eur J Hum Genet; 2004 May; 12(5):355-64. PubMed ID: 14722586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews.
    Durst R; Colombo R; Shpitzen S; Avi LB; Friedlander Y; Wexler R; Raal FJ; Marais DA; Defesche JC; Mandelshtam MY; Kotze MJ; Leitersdorf E; Meiner V
    Am J Hum Genet; 2001 May; 68(5):1172-88. PubMed ID: 11309683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population.
    Aksentijevich I; Torosyan Y; Samuels J; Centola M; Pras E; Chae JJ; Oddoux C; Wood G; Azzaro MP; Palumbo G; Giustolisi R; Pras M; Ostrer H; Kastner DL
    Am J Hum Genet; 1999 Apr; 64(4):949-62. PubMed ID: 10090880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin.
    Peretz H; Mulai A; Usher S; Zivelin A; Segal A; Weisman Z; Mittelman M; Lupo H; Lanir N; Brenner B; Shpilberg O; Seligsohn U
    Blood; 1997 Oct; 90(7):2654-9. PubMed ID: 9326232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selected genetic disorders affecting Ashkenazi Jewish families.
    Weinstein LB
    Fam Community Health; 2007; 30(1):50-62. PubMed ID: 17149032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the hexosaminidase A gene in Ashkenazi and non-Ashkenazi Jews.
    Peleg L; Karpati M; Gazit E; Raas-Rothschild A; Goldman B
    Biochem Med Metab Biol; 1994 Jun; 52(1):22-6. PubMed ID: 7917464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor.
    Karpati M; Gazit E; Goldman B; Frisch A; Colombo R; Peleg L
    Neurogenetics; 2004 Feb; 5(1):35-40. PubMed ID: 14648242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
    Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
    Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
    Rozenberg R; Pereira Lda V
    Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations.
    Diaz GA; Gelb BD; Risch N; Nygaard TG; Frisch A; Cohen IJ; Miranda CS; Amaral O; Maire I; Poenaru L; Caillaud C; Weizberg M; Mistry P; Desnick RJ
    Am J Hum Genet; 2000 Jun; 66(6):1821-32. PubMed ID: 10777718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews.
    Shpilberg O; Peretz H; Zivelin A; Yatuv R; Chetrit A; Kulka T; Stern C; Weiss E; Seligsohn U
    Blood; 1995 Jan; 85(2):429-32. PubMed ID: 7811996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
    Roa BB; Boyd AA; Volcik K; Richards CS
    Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.